We examined the effects of histamine and its agonists on the expression of the c-fos and c-myc proto-oncogenes at the transcriptional and translational levels in the human promonocytic U937 cell line. Histamine transiently increased cAMP and c-fos expression through H 2 receptors. Dibutyryl cAMP also increased c-fos mRNA and protein, and levels remained elevated even after 12 hr of treatment. Dose-dependence studies using histamine and dimaprit showed that the EC 50 values for cAMP production and c-fos increase were similar, suggesting that cAMP might be involved in c-fos induction via H 2 receptors. Furthermore, studies carried out using H7, a protein kinase A/protein kinase C inhibitor, blocked c-fos induction, whereas no effect was observed with bisindolylmaleimide, a specific protein kinase C inhibitor. No modification of c-myc expression could be detected on treatment with histamine or its analogues. Nevertheless, dibutyryl cAMP induced a down-regulation of the levels of this proto-oncogene. In addition, dibutyryl cAMP inhibited cell growth in a dose-dependent manner, whereas histamine failed to affect proliferation and differentiation of U937 cells. Cells pretreated with dimaprit showed a decrease in the cAMP response to subsequent addition of H 2 agonists, whereas the cAMP response to prostaglandin E 2 remained unaltered. This homologous mechanism of H 2 receptor desensitization was time dependent. These results indicate that histamine activates several mechanisms involved in the induction of differentiation, such as cAMP and c-fos production, but fails to promote differentiation of U937 cells, apparently due to the rapid desensitization of H 2 receptors.
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Histamine is an intercellular signal molecule that exerts its effect through H 1 , H 2 , and H 3 receptors (1). It is well known that human phagocytes possess H 2 receptors, which mediate activation of adenylyl cyclase with subsequent increases in cAMP and PKA activity (2) . This in turn modulates different cellular processes such as proliferation and differentiation. Recently, other cAMP-independent pathways have been described for H 2 receptors, including regulation of the breakdown of phosphoinositides (3, 4) , of intracellular Ca 2ϩ levels (5, 6) , and of phospholipase A 2 activity (7). The presence of H 1 and H 2 histamine receptors in U937 cells derived from the monocyte/macrophage lineage (8) has been reported (9, 10) . H 2 receptor activation produces an increase in cAMP formation (9, 10) , whereas the H 1 receptor seems to be coupled to enhancement of phosphoinositide turnover (9) . Certain subsets of early response genes code for transcription factors involved in nuclear signal transduction. For example, the c-fos gene is induced as an immediate early event by serum, growth factors, and phorbol ester (11) . The Fos and Jun proteins are the components of the activator protein-1 transcription factor that binds to the consensus sequence TGA(C/G)TCA (TRE) and regulates the transcription of several genes (12) . Although Jun is capable of binding to this sequence as a homodimer, the formation of the Jun/Fos heterodimer greatly enhances the ability of these proteins to stimulate transcription from activator protein-1 enhancer sequences (13) . Another early response gene, c-myc, has long been implicated in the control of normal cell growth, whereas its deregulation is related to the development of neoplasia (14) . Myc protein is a short-lived nuclear phosphoprotein that exhibits a dimerization domain structurally related to those described in a number of transcription factors (15) .
Different agents such as PMA (16) , interferon-␥ (17), vitaThis work was supported in part by grants from the University of Buenos Aires (FA005), Antorchas Foundation, and National Research Council of Argentina (CONICET).
) were lysed in 300 l of 50 mM Tris⅐HCl, pH 6.8, 2% SDS, 100 mM 2-mercaptoethanol, 10% glycerol, and 0.05% bromphenol blue and sonicated to shear DNA. Samples were then boiled for 5 min, and 20-l samples were electrophoresed in 12% SDS-polyacrylamide gels and transferred to nitrocellulose paper. The residual binding sites were blocked with 5% nonfat dried milk in TBST (20 mM Tris⅐HCl, pH 7.6, 137 mM NaCl, 0.05% Tween-20), and membranes were incubated with 2 g/ml concentration of the specific primary antibody in 3% nonfat dried milk in TBST. Rabbit sera against Myc, Jun, and Fos proteins were purchased from Santa Cruz Biochemicals (Santa Cruz, CA). All subsequent washes were performed in TBST. Reactivity was developed using an anti-rabbit polyclonal antibody linked to horseradish peroxidase and enhanced chemiluminescence reagents according to the manufacturer's instructions (Amersham International, Buckinghamshire, UK). cAMP determination. Cells were stimulated with different concentrations of histamine, H 2 agonist (dimaprit), or H 1 agonist (2-(3-trifluormethylphenyl) histamine) in Hanks' balanced salt solution containing 1 mM IBMX. Reaction was terminated by 3-min centrifugation at 3000 ϫ g followed by the addition of ethanol. Supernatants were centrifuged 10 min at 3000 ϫ g, and the ethanol phase was dried and resuspended in 50 mM Tris⅐HCl buffer, pH 7.4. The cAMP content was determined by competition with [ 3 H]cAMP for PKA, as described previously (9) .
Desensitization experiments. Pretreatment of cells with dimaprit was performed in Hanks' solution at 37°in a humidified atmosphere containing 5% CO 2 . Cells were exposed to 10 M dimaprit (maximal response) for periods ranging from 1 min to 3 hr in the absence of IBMX, after which cells were washed and resuspended at a density of 10 6 cells/ml in Hanks' solution containing 1 mM IBMX and exposed for 9 min to dimaprit to determine whether the histamine H 2 receptors could still generate a cAMP response.
Cell proliferation. Cells were seeded at 2 ϫ 10 5 cells/ml and incubated for diverse period of times (maximum, 6 days) with different doses of dimaprit, 2-(3-trifluormethylphenyl)histamine, dbcAMP, and forskolin. Cells were harvested, and their numbers were estimated using an hemocytometer chamber.
Cell differentiation. Control and U937 cells treated for 72 hr with 10 M dimaprit or 0.4 mM dbcAMP were incubated 15 min at 37°w ith murine anti-CD14, anti-CD11b (25) antibodies, or the isotypic control. Cells were immunolabeled by the addition of a goat antimurine IgG/fluorescein isothiocyanate conjugate. All of these reagents were purchased from DAKO (Carpinteria, CA). Labeled cells were analyzed in a FACStar plus flow cytometer (Becton Dickinson, San Jose, CA).
Chemotaxis assay. In vitro locomotion of control and treated U937 cells was assayed according to the micropore filter technique. Briefly, 10 5 cells in 0.5 ml of RPMI 1640 supplemented with 0.5% human serum albumin were seeded onto the top compartment of the chemotactic chamber placed in a 24-well culture plate. The top and bottom compartments were separated by a PVP-free polycarbonate filter with a pore size of 5 m. The bottom compartment was filled with 0.6 ml of control media alone or plus 5 nM rhC5a (26) . Chambers were incubated for 1-3 hr at 37°in a 5% CO 2 atmosphere. Migrating cells were collected and counted by flow cytometry (Cytoron; Ortho Diagnosis, Raritan, NJ).
NBT reduction. Treated and control cells were mixed with equal volumes of 0.2% NBT and 200 nM PMA in phosphate-buffered saline. After 1 hr of incubation at 37°, the proportion of cells containing intracellular formazan deposits was determined on May-GrunwaldGiemsa-stained cytospin slide preparations.
Data analysis. EC 50 values and doses required to reach maximal response were obtained by analyzing the concentration-response curves (see Figs. 2 and 6 ). Statistical analysis was carried out with Student's t test or one-way analysis of variance. A Bonferroni post hoc test for multiple pairwise comparisons was performed when significant differences were detected. Values of p Ͻ 0.05 were considered to indicate statistically significant differences.
Results
Time-dependent induction of c-fos expression by histamine and H 2 agonist. U937 cells treated with 10 M histamine or H 2 agonist showed a remarkable transient increase in c-fos levels after 30 min (Fig. 1, top) . Quantitative analysis of this assay clearly showed maximal levels of c-fos mRNA after 60 min of treatment. These mRNA levels consequently diminished, reaching values close to the basal level at 4 hr of treatment ( Fig. 1, bottom) . Identical experiments carried out in the presence of 10 M H 1 agonist showed no effects on the levels of c-fos mRNA. The levels of the control Dose-response analysis of the effects of histamine and the H 1 and H 2 agonists on the quantitative levels of c-fos mRNA. Concentration-response curves were performed after 1-hr incubation in the presence of histamine or the H 2 agonist. Both agents induced dose-dependent increases in the levels of c-fos mRNA (Fig. 2, top) . EC 50 values and doses required to obtain maximal response were obtained by densitometric analysis of the autoradiograms. The EC 50 values for histamine and dimaprit were 1.4 Ϯ 0.3 and 0.6 Ϯ 0.1 M, respectively, whereas the maximal response was obtained with doses of Ͼ10 M for both reagents (Fig. 2,  bottom) . Again, no change was observed in cells treated with the H 1 agonist.
The increase in c-fos expression is induced specifically via the H 2 receptor. A combined treatment with the agonist and antagonists showed that only H 2 receptors were directly linked to the increases in c-fos levels. As shown in Fig. 3 , the effect of histamine was completely blocked by famotidine, an H 2 antagonist, whereas no changes were seen with pyrilamine, an H 1 antagonist. These observations were reinforced by the fact that famotidine, but not pyrilamine, abrogates the increase in c-fos induced by the H 2 agonist. Neither pyrilamine nor famotidine was able to alter c-fos expression alone.
The stimulatory effect of dimaprit on c-fos mRNA levels is mediated by PKA activation. To investigate whether protein phosphorylation is involved in the mechanism of c-fos modulation, a number of assays were carried out in which H7, a PKA/PKC inhibitor (27) , was included before the addition of histamine or H 2 agonist to U937 in culture. The results shown in Fig. 4 demonstrate that H7 dramatically blocked the increase in c-fos mRNA levels evoked by histamine or dimaprit. In addition, dbcAMP, a PKA activator, induced an increase in c-fos transcript levels that could be blocked by H7. BM, a specific PKC inhibitor (28), did not modify c-fos expression induced by histamine or dimaprit but instead completely abolished the increase in c-fos mRNA evoked by PMA, a well-known PKC activator (29) . These results suggest that protein phosphorylation mediated by PKA is part of the mechanism involved in histamine-induced c-fos gene expression.
c-myc is not affected by histamine. As indicated in Histamine and H 2 agonist induce cAMP levels in U937 cells. Histamine and dimaprit produced a dose-dependent increase in cAMP levels, with a maximum accumulations of ϳ100-fold on the basal value for histamine and Ͼ50-fold for dimaprit, with EC 50 values of 1.8 Ϯ 0.2 and 0.7 Ϯ 0.2 M, respectively (Fig. 6) . The EC 50 values for histamine and the H 2 agonist that produced increase in cAMP levels were found to coincide with the EC 50 values that induce c-fos expression (Figs. 2, bottom, and 6 ).
c-fos and c-myc levels are regulated by dbcAMP. U937 cells in culture were supplemented for various period of times with 0.4 mM dbcAMP, after which both c-fos and c-myc mRNA levels were examined. As indicated in Fig. 7 , dbcAMP remarkably increased c-fos mRNA level within the first hour, and the level remain elevated for Ն12 hr after treatment. This sustained effect was not observed using histamine or the H 2 agonist. Under similar conditions, the levels of c-myc mRNA were markedly reduced within 1 hr of treatment with dbcAMP.
Levels of Fos and Myc proteins in U937 cells treated with H 2 histamine agonist and dbcAMP. Kinetic analysis of Fos and Myc protein content was carried out on cells treated with dimaprit or dbcAMP. Translation was found to follow a pattern that paralleled the corresponding oncogene mRNA levels. Dimaprit produced a transient increase in Fos protein with a maximal response after 2 hr, which remained higher than controls for Ն6 hr and progressively decreased to basal concentrations after 12-24 hr. In contrast, levels of this protein remain constantly elevated in cells exposed Յ24 hr to dbcAMP (Fig. 8) . Myc protein levels were not affected by dimaprit in cells treated Յ24 hr but showed a remarkable and progressive decrease when cultured in the presence of dbcAMP (Fig. 8) . Analysis of Jun protein levels showed a behavior similar to the one found for Fos in cells treated with dimaprit or dbcAMP (Fig. 8) .
Histamine does not induce changes in cell proliferation. Fig. 9 illustrate the results on U937 cell proliferation after 3 days of treatment with histamine, H 1 or H 2 agonist, or dbcAMP at the indicated concentrations. Neither histamine nor its agonists were able to inhibit cell division. In contrast, dbcAMP inhibited U937 cell proliferation. This effect was dose dependent, exhibiting an EC 50 value of 116 Ϯ 12 M. Forskolin showed a similar inhibitory effect with an EC 50 value of 19 Ϯ 6 M.
H 2 agonist has no effect on cell differentiation. Essentially all cells remained functionally undifferentiated after 3 days of treatment with dimaprit ( Table 1) . As expected, cell differentiation takes place in the presence of dbcAMP. This was judged by the ability of dbcAMP to promote reduction of NBT, to increase migration rates of cells challenged with the chemoattractant rhC5a, and to induce the expression of CD14 and CD11b myeloid differentiation cell surface antigens (Table 1) . Forskolin, an inducer of the PKA pathway, showed similar results to dbcAMP (data not shown).
Histamine H 2 receptor desensitization. The susceptibility of the histamine H 2 receptor to desensitization was further investigated in this cell line. Results showed a dra- molpharm.aspetjournals.org matic reduction in cAMP production by the H 2 agonist when U937 cells were pretreated with dimaprit. In fact, the agonist could no longer induce a response when cells were pretreated for 2 hr with 10 M concentration of the H 2 agonist. Halfmaximal desensitization was observed at 20 Ϯ 3 min after cell preexposure (Fig. 10) . To establish whether desensitization was restricted to the histamine H 2 receptor, PGE 2 -mediated cAMP induction was examined in cells pretreated with dimaprit. PGE 2 increased cAMP production in the U937 cell line for Ն2 hr. Identical assays carried out in the presence of forskolin showed similar results (Fig. 10, inset ).
Discussion
The current study reports the effects of histamine on the levels of two nuclear proto-oncogenes, c-fos and c-myc, in U937 cells. Results indicate that histamine and dimaprit induce a transient increase in the levels of c-fos that is specifically mediated through H 2 receptors.
The presence of this type of receptor in U937 cells was reported in a study by Gespach et al. (10) , in which H 2 receptors exhibit a classic pharmacological pattern described in the right atrium of guinea pig. In addition, the cAMP response to H 2 receptor stimulus obtained in the current study was concordant with data reported in the literature (1). The demonstration that the EC 50 values for cAMP and c-fos expression were similar suggests that this increase is modulated via cAMP-PKA. Studies performed in the presence of H7 showed dramatic blocking of the effects of histamine and its agonist on the expression of this proto-oncogene.
Previous studies performed by our group demonstrated that histamine modulates the turnover of phosphoinositides in U937 cells in a dose-dependent manner through H 1 receptors (9) . In addition, the regulation of PKC activity by the activation of this pathway via H 1 receptors has been described (1). Furthermore, the existence of diverse PKC isoenzymes with activity for distinct substrates in vitro has revealed differences that may indicate an even more pronounced specificity toward natural substrates under physiological conditions (29) . Therefore, unlike PMA, possibly histamine or H 1 agonists activate PKC isoforms that are unable to stimulate c-fos transcription via PKC. The fact that the H 1 agonist did not induce changes in c-fos mRNA levels supports the idea that the effect of histamine at this level is independent of PKC. In addition, pretreatment with bisindolylmaleimide, a selective PKC inhibitor, did not alter the expression of the c-fos proto-oncogene increased by either histamine or dimaprit. This allows us to conclude that the intracellular increase in cAMP through H 2 receptors, together with the increase in PKA activity, might be responsible for the increased levels of c-fos mRNA. This is supported by the fact that dbcAMP, a direct activator of PKA, also increased c-fos expression and can be blocked by H7.
The induction of c-fos by cAMP has been demonstrated in numerous systems. The characteristics of this control are partly cell-type specific, as illustrated by the very high and stable transcription levels of c-fos in cAMP-stimulated macrophages and a weaker and transient effect in other cells (30) . Enhanced c-fos expression associated with an increase in the intracellular concentration of cAMP have been described in systems in which this cyclic nucleotide can induce cellular proliferation [e.g., Swiss 3T3 cells (31) and dog thyroid cells (32) ].
Contrarily to the response of c-fos, we did not detect modifications in the expression of the c-myc proto-oncogene in cells treated with histamine or its agonists. These results differ from those described for other hematopoietic cell lines in which intracellular increases in cAMP by histamine in- Because gene expression regulation in general is not restricted to mRNA levels alone (37), the effects of H 2 agonist and dbcAMP on Fos, Jun, and Myc protein expression were also studied. Dimaprit transiently elevated Fos levels, whereas dbcAMP produced increases for longer periods of times. In addition, we observed that the levels of Jun protein, the other component of the activator protein-1 complex, in cells treated with H 2 agonist or dbcAMP showed similar patterns. A great deal of circumstantial evidence suggests that control of Myc function may be important during differentiation. Heightened Myc expression in murine erythroleukemia cells and monocytes can block differentiation (38) . It appears that the transient elevation in cAMP induced by H 2 agonist is insufficient to down-modulate Myc protein expression over the long term, whereas in cells incubated in the presence of dbcAMP, we clearly observed a significant and sustained reduction in Myc protein levels.
In many G protein-coupled systems, such as histamine receptors, prolonged exposure to agonists leads to a state of reduced responsiveness to these agents, a process termed "desensitization" (39) . In this regard, we show that the desensitization of H 2 receptors in U937 cells exhibits a half-life of 20 min and that by 120 min this process is complete. Furthermore, desensitization proved to be homologous because cells pretreated with dimaprit showed an intact cAMP response to both PGE 2 and forskolin. This is in agreement with the transient increase in c-fos expression and supports the hypothesis that this effect is mediated by cAMP. On the other hand, this rapid desensitization followed by a decrease in cAMP levels could be the basis for the lack of response in c-myc expression. In other cellular systems in which the desensitization of the H 2 receptor is retarded, histamine and its agonists down-regulate the levels of c-myc gene expression (40) .
We demonstrate here that histamine is incapable of inhibiting U937 cell proliferation despite the noticeable though transient increase in cAMP levels, whereas an important inhibition by dbcAMP could be observed. Accordingly, we have shown that forskolin and dbcAMP, but not dimaprit, induced a significant proportion of cells to acquire the ability to (i) produce superoxide anion, (ii) express cell surface maturation markers, and (iii) increase chemotaxis. Taken together, these results indicate that the binding of agonist to H 2 histamine receptors triggers an early specific response characterized by an increase in cAMP levels, but their rapid desensitization makes this response insufficient to induce differentiation of U937 cells. It could be possible that in promonocytic U937 cells, but not in normal progenitors, desensitization via H 2 receptors plays a significant role in reducing their capacity to reach terminal cell differentiation. Supporting this idea, although not rigorously related to this cell hierarchy, histamine has been reported to cooperate with granulocyte-colony stimulating factor in the induction of normal cell differentiation (40) . Therefore, a better understanding of this issue could make possible new avenues in therapeutic intervention.
